1 not yet recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Neuromyelitis Optica Spectrum Disorders (NMOSD): new trials by email Literature Review of Neuromyelitis Optica Spectrum Disorders (NMOSD) trials Research Report on Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder Eculizumab administration, High-dose corticosteroid pulse therapy, Plasma exchange (PE) - Neuromyelitis Optica Spectrum Disorders (NMOSD) | Phase 3 | Recruiting | Tianjin Medical University General Hospital | 198 | 2026-01-01 | 2026-05-14 |
| Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD Slow-tapering glucocorticoids + Inebilizumab, Rapid-tapering glucocorticoids + Inebilizumab - Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorders (NMOSD) | Phase 3 | Not yet recruiting | Tianjin Medical University General Hospital | 170 | 2025-09-01 | 2025-08-20 |
Neuromyelitis Optica (2) · Optic Neuritis (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Cranial Nerve Diseases (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Eye Diseases (2) · Immune System Diseases (2) · Myelitis, Transverse (2) · Nervous System Diseases (2) · Optic Nerve Diseases (2) · Optic Neuritis (1)
Plasma Exchange (1) · inebilizumab (1)
Tianjin Medical University General Hospital (2)
China (1)